2007
DOI: 10.1016/j.brainres.2007.07.081
|View full text |Cite
|
Sign up to set email alerts
|

Attenuation of actinomyosinII contractile activity in growth cones accelerates filopodia-guided and microtubule-based neurite elongation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
22
1
2

Year Published

2008
2008
2014
2014

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(31 citation statements)
references
References 43 publications
6
22
1
2
Order By: Relevance
“…In order to directly investigate the implication of NM II, we pre-incubated neurons, for 20 min before WIN stimulation, with the highly selective NM II ATPase inhibitor blebbistatin (25 µM) that blocks NM II in an actin-detached state without perturbing F-actin polymerization (Kovacs et al, 2004). Blebbistatin pre-treatment induced substantial morphological changes of the growth cone, which continued to move forward in a rather disorganized fashion (Figure 2G and Video 4), typically transforming the growth cone lamellipodia into several dynamically advancing filopodia, as reported previously (Rosner et al, 2007). Remarkably, blebbistatin completely abolished WIN-mediated retraction of these dynamically advancing F-actin-rich structures (Figure 2G,H, Figure 3E and Video 4), suggesting that the main force-generating factor downstream of CB1R activation is actomyosin contractility.…”
Section: Resultssupporting
confidence: 82%
“…In order to directly investigate the implication of NM II, we pre-incubated neurons, for 20 min before WIN stimulation, with the highly selective NM II ATPase inhibitor blebbistatin (25 µM) that blocks NM II in an actin-detached state without perturbing F-actin polymerization (Kovacs et al, 2004). Blebbistatin pre-treatment induced substantial morphological changes of the growth cone, which continued to move forward in a rather disorganized fashion (Figure 2G and Video 4), typically transforming the growth cone lamellipodia into several dynamically advancing filopodia, as reported previously (Rosner et al, 2007). Remarkably, blebbistatin completely abolished WIN-mediated retraction of these dynamically advancing F-actin-rich structures (Figure 2G,H, Figure 3E and Video 4), suggesting that the main force-generating factor downstream of CB1R activation is actomyosin contractility.…”
Section: Resultssupporting
confidence: 82%
“…Several studies in chick found that Y-27632 increases lamellipodia and filopodia protrusions from multiple neuronal subtypes (Loudon et al, 2006; Rosner et al, 2007), while Y-27632 significantly decreased filopodial protrusions from Xenopus spinal cord neuronal growth cones (Woo and Gomez, 2006). Conflicting results on the role of ephrins and Rho signaling are also present in cell migration assays.…”
Section: Discussionmentioning
confidence: 99%
“…The actin filaments in the lamellipodia are also predominantly oriented with their barbed ends distal, and move retrogradely. The retrograde flow of F-actin is augmented by the action of non-muscle myosin II, as demonstrated by the finding that specific inhibition of myosin II ATPase by the small molecule inhibitor blebbistatin attenuates F-actin retrograde flow (Medeiros et al, 2006;Burnette et al, 2008;Geraldo et al, 2008) and enhances filopodia extension (Rösner et al, 2007). All known isoforms of myosin II (IIA, IIB and IIC) are present in growth cones (Turney and Bridgman, 2005) and, as blebbistatin inhibits the activity of all three, it is not clear from these experiments which isoforms are important in retrograde flow.…”
Section: The Growth-cone Cytoskeletonmentioning
confidence: 99%